# US 2020/0347395 A1 · Plant promoter for transgene expression

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0347395 A1
- Document ID: US20200347395A1
- Status: Published application
- Kind: A1
- Application number: 16/758,649
- Filed: 2018-10-29
- Published: 2020-11-05
- Earliest claimed: 2017-10-30
- Assignees: Dow AgroSciences LLC; Pioneer Hi-Bred International, Inc.
- Applicants: Dow Agrosciences LLC; Pioneer Hi-Bred International, Inc.
- Inventors: Lyudmila Sidorenko; Cory M. Larsen; Geny Anthony; Shreedharan Sriram; Holly Jean Butler; Lynne E. Sims; Scott H. Diehn; Gilda M. Rauscher; Kevin G. Ripp; Knut Meyer
- Web page: https://patentgrep.com/patent/US20200347395A1

## CPC

- C07K 14/415: from plants
- C12N 15/8223: {Vegetative tissue-specific promoters}
- C12N 5/14: Plant cells
- C12N 15/8216: {Methods for controlling, regulating or enhancing expression of transgenes in plant cells}
- C12N 15/8222: {Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation}
- C12N 15/8274: {for herbicide resistance}
- C12N 15/8286: {for insect resistance}
- Y02A 40/146: Genetically Modified [GMO] plants, e.g. transgenic plants
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

This disclosure concerns compositions and methods for promoting transcription of a nucleotide sequence in a plant or plant cell, employing a promoter from a GmCAB2 gene. Some embodiments relate to a promoter or a 5′ UTR from a GmCAB2 gene that functions in plants to promote transcription of operably linked nucleotide sequences. Other embodiments relate to a 3′ UTR or a terminator from a GmCAB2 gene that functions in plants to promote transcription of operably linked nucleotide sequences.

## Claims

### Claim 1

A nucleic acid vector comprising a promoter operably linked to a heterologous polynucleotide sequence of:
a) a polylinker sequence;
b) a non-GmCAB2 heterologous coding sequence; or
c) a combination of a) and b);
wherein said promoter comprises a polynucleotide sequence that has at least 95% sequence identity with SEQ ID NO:2.

### Claim 2 (depends on 1)

The nucleic acid vector of claim 1, wherein said promoter is 1,376 bp in length.

### Claim 3 (depends on 1)

The nucleic acid vector of claim 1, wherein said promoter consists of a polynucleotide sequence that has at least 95% sequence identity with SEQ ID NO:2.

### Claim 4 (depends on 1)

The nucleic acid vector of claim 1, wherein said promoter is operably linked to a heterologous coding sequence.

### Claim 5 (depends on 4)

The nucleic acid vector of claim 4, wherein the heterologous coding sequence encodes a selectable marker protein, an insecticidal resistance protein, a herbicide tolerance protein, a nitrogen use efficiency protein, a water use efficiency protein, a small RNA molecule, a nutritional quality protein, or a DNA binding protein.

### Claim 6 (depends on 1)

The nucleic acid vector of claim 1, further comprising a terminator polynucleotide sequence.

### Claim 7 (depends on 1)

The nucleic acid vector of claim 1, further comprising a 3′ untranslated polynucleotide sequence.

### Claim 8 (depends on 1)

The nucleic acid vector of claim 1, further comprising a 5′ untranslated polynucleotide sequence.

### Claim 9 (depends on 1)

The nucleic acid vector of claim 1, further comprising an intron sequence.

### Claim 10 (depends on 1)

The nucleic acid vector of claim 1, wherein said promoter has tissue preferred expression.

### Claim 11

A transgenic plant comprising a promoter that has at least 95% sequence identity with SEQ ID NO:2 operably linked to a heterologous coding sequence.

### Claim 12 (depends on 11)

The transgenic plant of claim 11, wherein said plant is selected from the group consisting of Zea mays, wheat, rice, sorghum, oats, rye, bananas, sugar cane, Glycine max, cotton, Arabidopsis, tobacco, sunflower, and canola.

### Claim 13 (depends on 12)

The transgenic plant of claim 12, wherein said plant is Glycine max.

### Claim 14 (depends on 11)

The transgenic plant of claim 11, wherein the heterologous coding sequence is inserted into the genome of said plant.

### Claim 15 (depends on 11)

The transgenic plant of claim 11, wherein a promoter comprises a polynucleotide sequence having at least 95% sequence identity with SEQ ID NO:2 and said promoter is operably linked to a heterologous coding sequence.

### Claim 16 (depends on 11)

The transgenic plant of claim 11, further comprising a 3′ untranslated sequence.

### Claim 17 (depends on 11)

The transgenic plant of claim 11, wherein said heterologous coding sequence has tissue preferred expression.

### Claim 18 (depends on 11)

The transgenic plant of claim 11, wherein said promoter is 1,376 bp in length.

### Claim 19

A method for producing a transgenic plant cell, the method comprising the steps of:
a) transforming a plant cell with a gene expression cassette comprising a GmCAB2 promoter, wherein said promoter comprises a polynucleotide sequence that has at least 95% sequence identity with SEQ ID NO:1, operably linked to at least one polynucleotide sequence of interest;
b) isolating the transformed plant cell comprising the gene expression cassette; and,
c) producing a transgenic plant cell comprising the GmCAB2 promoter of operably linked to at least one polynucleotide sequence of interest.

### Claim 20

A method for expressing a polynucleotide sequence of interest in a plant cell, the method comprising introducing into the plant cell a polynucleotide sequence of interest operably linked to a GmCAB2 promoter, wherein said promoter comprises a polynucleotide sequence that has at least 95% sequence identity with SEQ ID NO:1.
